Greenwich LifeSciences, Inc. (GLSI)
15.90
-0.05
(-0.31%)
USD |
NASDAQ |
Sep 08, 16:00
15.67
-0.23
(-1.45%)
Pre-Market: 20:00
Greenwich LifeSciences Shareholders Equity (Quarterly) : 3.117M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.117M |
| March 31, 2026 | 5.270M |
| December 31, 2025 | 0.3532M |
| September 30, 2025 | 2.185M |
| June 30, 2025 | 1.440M |
| March 31, 2025 | 1.312M |
| December 31, 2024 | 2.534M |
| September 30, 2024 | 4.983M |
| June 30, 2024 | 5.875M |
| March 31, 2024 | 5.121M |
| December 31, 2023 | 6.700M |
| September 30, 2023 | 8.853M |
| June 30, 2023 | 10.65M |
| March 31, 2023 | 11.68M |
| December 31, 2022 | 13.21M |
| September 30, 2022 | 15.41M |
| Date | Value |
|---|---|
| June 30, 2022 | 16.97M |
| March 31, 2022 | 19.51M |
| December 31, 2021 | 26.83M |
| September 30, 2021 | 28.46M |
| June 30, 2021 | 29.16M |
| March 31, 2021 | 29.75M |
| December 31, 2020 | 27.63M |
| September 30, 2020 | 4.658M |
| June 30, 2020 | -1.458M |
| March 31, 2020 | -1.421M |
| December 31, 2019 | -1.350M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -10.12M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.876M |
| Total Liabilities (Quarterly) | 5.759M |
| Current Ratio | 1.541 |